CANINE HIP DYSPLASIA - PART VI

by:  Susan Thorpe-Vargas PhD, John Cargill MA, MBA, MS

Treatment of this disease must be tailored specifically
to the needs of your pet, whether using conventional
or alternative medicine

Anchor Jump Menu:
Chiropractic Acupuncture Drug Therapy Nutritional Therapy Gags
 Physical Therapy & Exercise Conclusions  Credits    

This is the sixth part in a series on canine hip dysplasia. What follows is written from the perspective that the readers of the series are conscientious breeders who are the guardians of the genetic pools that constitute their breeds. While this series of articles will not replace a stack of veterinary medical texts, it is a relatively in-depth look at the whole problem of a canine hip dysplasia. Furthermore, the series is designed to be retained as a reference. When you finish reading it you will have a sufficient background to make rational breeding choices and will be able to discuss the subject from an informed basis with your veterinarian. You may not like what you read, but you will be more competent to deal with the problem.

Conclusions from Part I:

Genetics is the foremost causative factor of canine hip dysplasia. Without the genes necessary to transmit this degenerative disease, there is no disease. Hip dysplasia is not something a dog gets; it either is dysplastic or it is not. An affected animal can exhibit a wide range of phenotypes, all the way from normal to severely dysplastic and functionally crippled. Hip dysplasia is genetically inherited.

Conclusions from Part II:

While environmental effects, to include nutrition and exercise, may play a part in mitigating or delaying the onset of clinical signs and clinical symptoms, hip dysplasia remains a genetically transmitted disease. Only by rigorous genetic selection will the incidence rate be reduced. In the meantime, it makes sense to have lean puppies and to avoid breeding animals from litters that showed signs of hip dysplasia. It is probable that even normal exercise levels may increase the phenotypic expression of CHD of a genetically predisposed dog. Stay away from calcium supplementation of any kind; all it can do is hurt. There is no conclusive evidence that vitamin C can prevent hip dysplasia, but there is some evidence that vitamin C may be useful in reducing pain and inflammation in the dysplastic dog.

Conclusions from Part III:

Canine hip dysplasia can be difficult to diagnose, as a number of other orthopedic neurological, autoimmune and metabolic problems may mimic it. Controversy surrounds the question of positioning for hip X-rays and what part joint laxity plays in hip dysplasia. Hip dysplasia may be more common in large and giant breeds and is one of the most over-diagnosed and misdiagnosed conditions.

Conclusions from Part IV:

Sadly, no breed registry in the United States requires genetic screening of parents as a prerequisite for litter registration or even offers a "fitness for breeding" certification. The current registries for hip dysplasia (and other genetically transmitted problems) cover so little of the American Kennel Club-registered dog population that their impact so far has been minimal. The tools we need are there. Joint responsibility for failing to use the tools at hand lies with the AKC, United Kennel Club, parent clubs and individual breeders.

Conclusions from Part V:

The two major methods of diagnosing canine hip dysplasia available to the fancy in the United States are those followed by OFA and those followed by PennHIP. Both are diagnostic; however, the hip-extended protocol followed by OFA may produce false-negative results. The protocol followed by PennHIP has a prognostic or predictive capacity through the use of statistics and a carefully guarded data base that allows a prediction to be made with respect to the probability of phenotypic expression of canine hip dysplasia. No one has a clear quantification of the gray area between obviously clear and obviously dysplastic hips.

This article will address the long-term medical management of canine hip dysplasia, the goals of which are to relieve pain, restore function and hopefully mitigate or delay the progression of the disease. There are philosophical choices to be made based on the psyche and the general approach to life of the individual animal. Some breeds are noted stoics, able to tolerate what would appear to be a great deal of pain. For such animals, restoration of function is the greatest gift. For other animals more susceptible to pain, relief of that pain may be the greatest gift. Much of the philosophy of medical management of canine hip dysplasia must come from the animals themselves. The authors both are more experienced with Northern breeds (Akitas and Samoyeds), which tolerate pain well; however, our experience covers other breeds as well. The philosophy of treatment must come from multiple sources: from traditional medicine, holistic medicine, acupuncture and even chiropractic.

Caveat: Before starting medical treatment, surgical procedures may be necessary to correct anatomical malformations. Such surgical procedures will be addressed in the seventh and eighth articles in this series.

Back to top

 

CHIROPRACTIC

William Inman, D.V.M., a clinician working in the Seattle area, is the reason we have included chiropractic. Inman's research, presented in the third article in this series suggests that spinal conditions, especially subluxation of between the eighth and tenth thoracic vertebrae, can cause a neurological condition that mimics the symptoms and signs of canine hip dysplasia. Inman's treatment method includes the traditional chiropractic "spinal adjustment," but with a twist. He has had numerous successes with a device called the "Activator." This instrument applies a small force very quickly on the affected spinal segment. Inman calls this technique "Veterinary Orthopedic Manipulation" and maintains that with this device he can "reactivate" the neurological pathway that has been compromised. The problem with discounting this whole process as being just a little too "New Age" lies in the number of apparent successes he has had.

Ask the owner of a paralyzed Dachshund and the 30 or more other people (including respected dog breeders, veterinarians and chiropractors) who saw the Dachshund start walking after only one such treatment. This little dog had been through the veterinary process and its owner was preparing to put it down after traditional veterinary medicine had failed to relieve the pain or restore the function. In a last-ditch effort to help her dog the owner brought her to a seminar hosted by the Wenatchee (Wash.) Kennel Club on April 22. The results were those described above. The case is definitely anecdotal; however, Inman has too many such cases to be dismissed out of hand, even by those in the mainstream of veterinary medicine.

With a background in genetics, neuroanatomy and neuropathology, Inman still questions the mechanism of how his technique works. What is it that may be happening at the cellular level that promotes healing? Why is it that an animal has to be "readjusted" periodically on a specific schedule for the results to stick? "Once the body has been returned to normal neurologic function via adjustment, it stays in adjustment for about three days. Months to years of functioning out of adjustment impinge on this newly rehabilitated neurologic ability, and the spine slips back to its previous out-of-adjustment condition. This is why further adjustments are necessary . At three, seven, 14, 21, 42 and 70, the body falls out of adjustment... ."1From the authors' perspective further research is clearly indicated, but meanwhile, this option of chiropractic is available to that segment of the dog population not suffering with the genetic disease of hip dysplasia, but from subluxation of the spine between the eighth and tenth vertebrae.

Back to top

 

ACUPUNCTURE

While relatively few Western veterinarians are using acupuncture, Western medicine is beginning to respect its potential and to practice it. As with many things in life a full understanding of the process is unnecessary for employing it. In physics, for example, light and electricity are poorly understood, yet the modern way of life is predicated on the use of both light and electricity. Acupuncture survives from a time before modern science and physical mechanisms were described in philosophical terms that do not hold up to strict scientific examination, yet the phenomena exists. This appears to be the state of acupuncture in medicine and in veterinary medicine. A great body of anecdotal evidence exists to suggest that acupuncture has potential for at least temporarily reducing pain and promoting natural healing. Acupuncture has a following among not only dog people but horse people, and many are the accounts of lame animals being restored to full function. As with Inman's chiropractic example, acupuncture has too many apparent successes to be discounted without further study.

Back to top

 

DRUG THERAPY

Because Hip Dysplasia results in abnormal forces being applied to the coxofemoral joint one of the most effective treatments is control of the dog's weight. If indicated, even small amounts of weight loss are productive. Restricted activity also should be considered not only to avoid excessive wear on the affected joint, but to control transient inflammation. Even so, most of the pharmacological treatment alternatives function by reducing the inflammatory response. These drugs can be divided into corticosteroids, which can include but are not limited to methylprednisolone, dexamethasone and prednisone and a variety of NSAIDs (non-steroidal anti-inflammatory drugs). Although useful in the acute stage, the corticosteroids are inappropriate for long-term treatment modalities due to their multiple undesirable side effects. Besides suppression of the immune system and loss of adrenal function, the use of corticosteroids can cause increased appetite increased thirst and gastrointestinal ulceration. Other research also indicates that corticosteroids can disrupt the articular cartilage matrix by inhibiting proteoglycan synthesis. 2,3Proteoglycan is necessary for stiffness and compressibility of the matrix. Fortunately, this effect is reversible within two or three weeks. Experimenting to determine the right interval between injections may be necessary.

NSAIDs are not without their drawbacks, either. Common aspirin (acetylsalicyclic acid) can cause vomiting and bloody stools; bleeding times may be extended due to irreversible inhibition of platelet function, and severe overdose can lead to an abnormally high fever, electrolyte imbalance, renal hemorrhage, convulsions and coma. Clotting time returns to normal within several days, however, as a result of normal platelet turnover. There is some indication that though aspirin is often the drug of choice, it may possibly accelerate the degeneration of articular cartilage.

Another drug used to relieve the symptoms associated with hip dysplasia is phenylbutazone. This drug4has a potentially serious side effect in that it depresses bone marrow formation. Bone marrow is the site of red blood cell maturation. Not yet approved for dogs by the Food and Drug Administration is the promising anti-inflammatory drug carprofen. Clinical trials have shown it is a more effective anti-inflammatory than both aspirin and phenylbutazone, and when compared to placebo it is 24.8 times more efficacious. In a double-blind study of 209 dogs, it was therapeutic in relieving pain, lameness and contralateral (opposite-side) weight-bearing.5 The drug also increased range of motion and reduced crepitus (the dry crackly sound when two dry articular surfaces rub together). An added benefit is that carprofen also seems to have a reduced potential for inducing gastrointestinal problems.

Caution: Of these drugs, only aspirin and phenylbutazone are FDA-approved for use in dogs. 6

"However, few NSAIDs are approved by the U.S. Food and Drug Administration for use in dogs, which has resulted in the empirical use of those approved in humans with sometimes disastrous results." In 1987 NSAID exposures comprised 8 percent of all human and veterinary medication calls to the Illinois Animal Poison Information Center.

"Many of  these newer  NSAIDs have a small margin of safety,  due to long half lives and low rates of elimination." 7

A few years ago dimethyl sulfoxide(DMSO), an industrial solvent, became a popular, though unapproved and unproven, treatment for arthritic joints. DMSO is a free-radical scavenger and is reported in the popular press to produce favorable results. Caution is advised.

Back to top

 

NUTRITIONAL THERAPY

The common mechanism for most of the anti-inflammatory drugs is inhibition of prostaglandin E2synthesis. Also referred to as the arachadonic "cascade," these drugs function by blocking the activity of the enzyme cyclooxygenase. What most people do not realize is that the antioxidant vitamins, d-alpha-tocopherals (the most biologically available form of vitamin E) and calcium ascorbate (a more effective form of vitamin C), also modulate PGE2 synthesis by inhibiting cyclooxygenase and stabilizing the cell membrane. Even though dogs manufacture their own vitamin C, to be therapeutically effective the blood plasma concentrations of these two vitamins must be maintained at a higher than normal value. Therefore, the form of the vitamin is important, and the amount ingested is higher than that suggested by the Association of American Feed Control Officials. These nutritional supplements are not useful for acute symptoms, but if taken daily and consistently, they can be reduce inflammation without any detrimental side effects.

An added benefit of these two vitamins is that they scavenge free-radicals (highly reactive and unstable compounds generated in mammalian cells as a result of cellular metabolism and cell damage), and when taken together vitamin C can regenerate the "reduced" form of vitamin E so that it can be recycled by the cell. Free-radicals are formed also in the inflammation process and when the animal is exposed to various environmental pollutants, including ultraviolet light. Besides being implicated in arthritic disease process, free-radicals are associated with the onset of cancer, aging, cataracts, neurologic disorders and a reduced immune function. Edward A. Moser, M.S., V.M.D., suggests in his article in the November/December 1994 issue of Veterinary Technician, "For a thirty pound dog, giving approximately 80 I.U. of vitamin E [and] 50 mg of Vitamin C can safely be recommended. Smaller dogs need proportionately less, larger dogs proportionately more."8 Other sources would consider this a very conservative dosage. In a Norwegian study, 30 mgs/kg of body weight of polyascorbate was given three times a day for six months.9 (A kilogram is 2.2 pounds)

Approximately 77 percent of the dogs treated showed marked improvement after six months, and 32 dogs out of the 45 diagnosed with hip dysplasia were symptom-free after only one week. Polyascorbate is a mineralized form of vitamin C that aids in the absorption and retention in the body's tissues, and because it has a neutral pH it does not cause gastric upset. Ascorbic acid, the vitamin C we are most familiar with, is too rapidly excreted to be effective, can irritate the lining of the digestive tract, and at the higher dosage recommended will cause the formation of crystals in the urinary tract.

Back to top

 

GAGS

The drugs and nutritional supplements mentioned so far either retard the breakdown of joint components or reduce pain and inflammation, thus improving the quality of life for the dog. None of them, except calcium ascorbate, are able to repair cartilage that has been compromised. While vitamin C is necessary for maintenance of collagen, it is also a carrier of activated sulfates needed for the synthesis of glycosaminoglycans (GAGS). An injectable form of polysulfated glycosaminoglycan called Adequan is in the process of being approved for dogs by the FDA. Considered a chondro-protective drug, it is already available in Canada for dogs and licensed for horses here in the United States. Previous laboratory trials (in-vitro cell-line experiments) demonstrated its effectiveness in promoting the synthesis of cartilage matrix components. It also slows down the destruction of these cartilage components, decreases joint inflammation, restores the normal hyaluronic acid content in the synovial fluid (increases viscosity) and relieves pain.10,11 Another study conducted at Cornell University has shown that PSGAG (polysulfated glycosaminoglycans), given prophylactically, are able to improve coxofemoral joint congruity in puppies prone to hip dysplasia.12

To understand how this product works, let us review a few pertinent facts about joint structure and the articular cartilage. Stress due to the abnormal biochemical forces in the dysplastic joint causes injury to the chondrocytes and the release of various destructive enzymes. Chondrocytes are responsible for the synthesis of collagen and proteoglycans, which constitute the ground substance (matrix) of articular cartilage. Acting somewhat like "glue," the matrix proteoglycans play an important role in the structural integrity of cartilage. A number of destructive enzymes have been isolated that break down joint matrix components; among these are the metalloproteinases. These enzymes break down proteins and depend upon the metal ions CA++ (calcium) and Zn++ (zinc) for their activity. Adequan is thought to function by inhibiting the activity of these metalloproteinases and other degenerative mechanisms, but a dual role has been suggested in that it may also act by stimulating the synthesis of proteoglycans and collagen by the chondrocytes.13

Both the femoral head and the acetabulum are covered with articular cartilage. The entire surface area is lubricated by synovial fluid, which is composed of and ultrafiltrate of plasma and glycosaminoglycan hyaluronic acid. Viscosity is the result of hyaluronic acid concentration, so anything that affects the concentration of HA also affects the lubricating potential of the synovial fluid. Synovial fluid, the source of nutrition for the articular cartilage, functions by eliminating metabolic waste products, and is contained by a fibrous structure called the joint capsule. The joint capsule itself is composed of an inner layer called the synovial membrane and another consisting of a fibrous outer covering. Thus most of the pathologic changes associated with hip dysplasia and subsequent degenerative joint disease can be attributed to the various chemical changes in the synovial fluid and the articular cartilage.

No toxic effects from the use of polysulfated glycosaminoglycans in dogs have been reported in the literature, but caution should be taken for use in those breeds with known blood coagulation problems such as von Willebrand's disease (vWD) or hemophilia.14 Furthermore, this drug should not be used in conjunction with other drugs that interfere with normal blood clotting mechanisms. Other studies have shown that it can inhibit the complement cascade (part of the secondary immune response), and suppress neutrophil activity.15 Neutrophils are white blood cells that surround and digest foreign substances, including bacteria and viruses. So its use would be proscribed if the dog had an active infection, especially joint sepsis.

Two nutritional products are now being suggested for management of degenerative joint disease as possible alternatives or adjuncts to the drug Adequan, Glyco-Flex and Cosequin. These two products have the advantage of being administered orally, and so far the data supports their manufacturers' claim that absorption readily occurs from the gastrointestinal tract. 16

Glyco-Flex is a freeze-dried preparation of the New Zealand green-lipped mussel, Perna canaliculus, to which brewer's yeast and alfalfa have been added to reduce the marine odor and increase palatibility. The end result is a complex mixture of proteins, mixed glycosaminoglycans, amino acids, chelated minerals, enzymes and vitamins. The activity of the Perna mussel is probably the effect of several ingredients working in combination.

Cosequin 17,18 is a patented nutraceutical sold only to vets which has numerous clinical studies currently under way at veterinary universities. The active ingredients in Cosequin are glucosamine HCL (hydrochloride), purified chondroitin sulfate and manganese ascorbate. Currently this product is being evaluated by veterinary orthopedic surgeons for use in dogs and the results are encouraging. Other studies are looking at Cosequin's ability to stabilize articular surfaces of the joint and improve the joints' overall function.19

Back to top

 

PHYSICAL THERAPY AND EXERCISE

Owner-conducted physical therapy is an indispensable component of treatment. Heat, followed by range of motion exercises, may provide temporary relief. Often favorable results are obtained by gently moving the affected joint through a full range of motion several times daily. This may prevent capsular contraction and its increased pressured on the articular cartilage. A variety of forms of heat are available., ranging from the unsophisticated heating pad to ultrasound and diathermy. Simplicity, availability and cost are considerations. A heating pad under the bedding is often appreciated as may be seen by the dog resting with the most affected hip placed over the heating pad. Where possible, refraining from weight-bearing on affected joints may help. Similarly, vertical load reduction on joints may help. Thus in some cases of CHD, the dog should be prevented from going up or down stairs, from jumping up or jumping down from a height.

Muscle atrophy can cause increased stress on the affected joint. Graduated exercise may be effective to correct this muscle imbalance so characteristic of CHD (overdeveloped shoulder girdle; weak hips). In any case, weight loss, even if it means a "lean and hungry" look in old age, often pays large dividends in quality of life for the animal. Simple measures such as bedding changes can make a difference. Many an older dog, which in younger days would refuse a bed, preferring instead hard concrete or linoleum floors, may accept and be helped by a piece of plush pile carpet or a pad of some kind.

Warning: medical management of a degenerative joint disease, such as canine hip dysplasia, is simply management, not cure. Both you and your animal have to learn to live with the condition and to adjust your lifestyles accordingly. In mild cases, especially of the insidious form of CHD, little adjustment may be required, other than to precede bouts of increased activity with a "pre-dose" of aspirin. Be very careful that you do not fall in the trap that many human patients and their dogs fall into: When the pain is gone and the inflammation is reduced there is an extreme tendency to overdo it. The pain will come back to visit if the animal gives in to temptation to romp until it drops.

Back to top

 

Conclusions:

For many animals, canine hip dysplasia is a manageable condition, and they can lead relatively normal and active lives given that caution is exercised. Every dog is different in its response to pain, and the treatment protocol needs to be tailored specifically to the particular animal. Only aspirin and phenylbutazone ("bute") are FDA-approved drugs for use in dogs, and they are not without serious side effects. Corticosteroids are dangerous and may require experimenting to find proper dosage levels and intervals. Favorable results have been reported from chiropractic, physical, drug and nutritional therapy.

The final two articles in this series will cover surgical intervention in the management of canine hip dysplasia. Surgical measures are measures of last choice. We hope however, to make the case that surgery may be a viable choice, and even an economically sensible choice, especially for companion dogs for the elderly, assistance, drug-sniffing, search-and-rescue and other specially trained dogs where costs and time associated with training and replacement are high.

Back to top

 

CREDITS

References

  1. Personal Communication with Dr. William Inman, Lake City Animal Hospital, 13045 Lake City Way N.E. Seattle, WA. 98125; (206)362-0909.

  2. Peltier, J.P.; Peltier, J.M. "Protective effects of corticosteroids on cartilage lesions and osteophyte formation in the Pond-Nuki model of dog osteoarthritis." ArthritisRheum. 32:181-193, 1989.

  3. McIllwraith, C.W. "Current concepts in equine degenerative joint disease." J Am Vet Med Assoc.180:239-250. 1982.

  4. Pederson, N.C.; Wind, A.; Morgan, J.P.; Pool, R.R. "Joint diseases of dogs and cats." in Textbook of Veterinary Internal Medicine, Ed. 2, Vol. 2 (Ettinger, S.J.-ed.). Philadelphia: WB Saunders Co. 1989.

  5. Holtzsinger, R.H.; Parker, R.B.; Deale, B.S.; Friedman, R.I. "The Therapeutic efficacy of carprofen (Rimadyl-VTM) in 209 clinical cases of canine degenerative joint disease." VCOT. 1992. Vol. 5, pp. 140-144.

  6. Boulay, J.; DeAngelis, M.; Kincaid, S.; Leeds, E.; Prostredny, J.; Todhunter, R. "Medical Therapy of Osteoarthritis in Dogs." Veterinary Exchange. Veterinary Learning Systems Co. 1995.

  7. Holtzsinger, R.H.; Parker, R.B.; Deale, B.S.; Friedman, R.I.

  8. Moser, E.A. "Antioxidant vitamins in canine nutrition." Veterinary Technician. Nov./Dec. 1994, pp.587-589.

  9. Berge, G.E. "Polyascorbat, et behandlings-alternativ ved kroniske forandringer I stotte og bevegelsesapparetet hos hund." ("Polyascorbate, an interesting alternative by problems in the support and movement apparatus in dogs.") Norsk Veterinaertidsskrift (Norwegian Vet J), August/September 1990;102:581-582.

  10. Altman, R.D.; Dean, D.D.; Muniz, O.E.; Howell, D.S. "Therapeutic treatment of canine osteoarthritis with glucosaminoglycan polysulfuric acid ester." Arthritis and Rheum. Vol. 32, No. 10, Oct. 1989.

  11. Clark, D.M. "Current concepts in the treatment of degenerative joint disease." Compen Cont Educ Prat Vet. 13(9):1991, pp. 1439-1447.

  12. Lust, G.; Williams, A.J.; Burton-Wurster, N.; Beck, K.A.; Rubin, G. "Effects of intramuscular administration of glycosaminoglycan sulfates on signs of incipient hip dysplasia in growing pups." Am J Vet Res. Vol. 53, No. 10, pp. 1836-1843.

  13. Altman, R.D.; Dean, D.D.; Muniz, O.E.; Howell, D.S.

  14. Beale, B.S.; Goring, R.L.; Clemmons, R.M.; Altman D. "Effect of semi- synthetic polysulfated glycosaminoglycan on the hemostatic mechanism in the dog." Pro ACVS. 25:430, 1990.

  15. Gustafson, S.B.; McIlwraith, C.W.; Jones, R.I. "Comparison of the effect of polysulfated glycosaminoglycan, corticosteroids, and sodium hyalurnate in the potentiation of a subinfective dose of Staphlococcus aureus in the midcarpal joint of horses." Am J Vet Res. 50(12): pp. 2014-2017. 1989.

  16. Veterinary Exchange.

  17. Setnicker, I.; Giachetti, C.; Zanolo, G. "Pharmacokinetics of Glucosamine in the dog and man." Artneimittleforschung. 39(2):pp. 729-736. 1986.

  18. Tesoriere, G.; Dones, F.; Magestro, D.; Castagetti, I. "Intestinal absorption of glycosamine and N-acetylglycosamine." Experimentia. Vol. 28, pp. 770-71. 1972.

  19. Veterinary Exchange.

CREDITS:

Susan Thorpe-Vargas has a doctorate in immunology and has an extensive chemistry and lab background. She has been involved in numerous Environmental Protection Agency cleanup sites. Susan also raises and shows Samoyeds.

John Cargill, Retired Officer of Marines, statistician and science writer, grew up with Airedale Terriers and American Foxhounds but lives on a boat in Florida with his 5-year-old Akita.

Susan and John won the Dog Writers Association of America's Maxwell Medallion and the Iams® Eukanuba® Canine Health Award for their articles on canine genetics that appeared in DOG WORLD.

Reproduced with permission.

 CANINE HIP DYSPLASIA - PART V

by:  {Article Author}

Predicting the Abnormal Hip

An evaluation method is needed that is not only diagnostic but
which can predict the probability of canine hip dysplasia.

nchor Jump Menu:
 Preventing Genetic Depletion Orthopedic Registries: Hip or Hype? Predicting Genotype  The Role of Hip Laxity Developing Better Diagnostic Methods
 Identification Methods Conclusions Credits    

This is the fifth part in a series on canine hip dysplasia. What follows is written from the perspective that the readers of the series are conscientious breeders who are the guardians of the genetic pools that constitute their breeds. While this series of articles will not replace a stack of veterinary medical texts, it is a relatively in-depth look at the whole problem of a canine hip dysplasia. Furthermore, the series is designed to be retained as a reference. When you finish reading it you will have a sufficient background to make rational breeding choices and will be able to discuss the subject from an informed basis with your veterinarian. You may not like what you read, but you will be more competent to deal with the problem.

 

Conclusions from Part I:

Genetics is the foremost causative factor of canine hip dysplasia. Without the genes necessary to transmit this degenerative disease, there is no disease. Hip dysplasia is not something a dog gets; it either is dysplastic or it is not. An affected animal can exhibit a wide range of phenotypes, all the way from normal to severely dysplastic and functionally crippled. Hip dysplasia is genetically inherited.

Conclusions from Part II:

While environmental effects, to include nutrition and exercise, may play a part in mitigating or delaying the onset of clinical signs and clinical symptoms, hip dysplasia remains a genetically transmitted disease. Only by rigorous genetic selection will the incidence rate be reduced. In the meantime, it makes sense to have lean puppies and to avoid breeding animals from litters that showed signs of hip dysplasia. It is probable that even normal exercise levels may increase the phenotypic expression of CHD of a genetically predisposed dog. Stay away from calcium supplementation of any kind; all it can do is hurt. There is no conclusive evidence that vitamin C can prevent hip dysplasia, but there is some evidence that vitamin C may be useful in reducing pain and inflammation in the dysplastic dog.

Conclusions from Part III:

Canine hip dysplasia can be difficult to diagnose, as a number of other orthopedic neurological, autoimmune and metabolic problems may mimic it. Controversy surrounds the question of positioning for hip X-rays and what part joint laxity plays in hip dysplasia. Hip dysplasia may be more common in large and giant breeds and is one of the most over-diagnosed and misdiagnosed conditions.

Conclusions from Part IV:

Sadly, no breed registry in the United States requires genetic screening of parents as a prerequisite for litter registration or even offers a "fitness for breeding" certification. The current registries for hip dysplasia (and other genetically transmitted problems) cover so little of the American Kennel Club-registered dog population that their impact so far has been minimal. The tools we need are there. Joint responsibility for failing to use the tools at hand lies with the AKC, United Kennel Club, parent clubs and individual breeders.

This article will cover the Orthopedic Foundation for Animals vs. PennHIP controversy, the requirement and desirability of an evaluation method that is not only diagnostic but also prognostic with an ability to predict the probability of phenotypic expression of hip dysplasia. Hand in hand with these methods goes the requirement for positive identification rather than the honor system currently in place and the concept of "open" genetic registries in order that genetic pedigree research can be done.

The first four articles in this series have generated many letters. In response, we restate that dogs of any recognizable breed, i.e., non-feral dogs, are inbred on a relatively small number of genes. Each breeding to members of the same breed constitutes continued inbreeding and thus further reduces the gene pool (genetic depletion), thus giving increased probability that recessive traits-desirable and undesirable-will match from each donor and will be expressed phenotypically in their get. We restate that it is desirable to inbreed (and line-breeding is inbreeding) to maintain breed characteristics. Unfortunately, over time this will cause more problems than it will solve, as virtually every dog (and human) carries several defective genes.

Back to top

 

PREVENTING GENETIC DEPLETION

A basic fundamental fact of genetics is that genetic health decreases with every generation of breeding within a breed. This point must be made very clear. Only 10 to 30 genes distinguish one breed from the next, yet in the dog thousands of recessive and co-dominant genes also become fixed in the genetic makeup of a breed. The only way to prevent genetic depletion and its resultant inbreeding depression is to outcross for hybrid vigor.

The various registries will have to understand the genetics of the situation: To maintain genetic vigor, breeds will have to outcross. In the near term this heretical necessity can be temporarily staved off through restricting stud use, as is being done in some European breed clubs. AKC, in recent years, literally saved the Dalmatian from extinction (nobody wanted a breed of deaf dogs, regardless of other characteristics) by allowing breeding to non-Dalmatians. Similarly in Europe, Dutch Shepherd Dogs were outcrossed with the Belgian Tervuren, and Bernese Mountain Dogs were crossed with Newfoundlands. Some will decry this practice, calling it the blackest of heresy; others will rejoice in the genetic salvation. In the meantime, genetic screening and open registries of genetic traits could allow the identification and breeding to the least genetically related animals in a breed's gene pool.

"therefore, the breeder controls the occurrence of hip dysplasia in his/her breed." 1

This is a quote from a recent memorandum from the OFA to the breed club representatives. So once again breeders must take the blame, yet how many of you have bred an OFA "normal" to another OFA "normal" and still produced dysplastic puppies? Some unscrupulous breeders commit fraud and offer a dog for OFA certification using the papers of another animal,, but most of us are conscientious breeders. We love our dogs and our breed and really want to eradicate this insidious disease.

Back to top

 

ORTHOPEDIC REGISTRIES: HIP OR HYPE?

Could something be wrong with the current method of evaluating an animal for hip dysplasia? Where are the scientific papers that prove the efficacy of the OFA diagnostic method? Where are the peer reviews of these papers? From what population data do they base their conclusions?

What is population data? It is a term that statisticians use. It isn't feasible to check every single dog for a particular condition so one simply checks a sample population. However, to be accurate that sample must truly represent the entire population. It is our contention that the OFA is basing its conclusions on self-selected and therefore biased, data. The OFA does not require of veterinarians that all radiographs of client dogs taken for initial evaluation be submitted to OFA. Each breeder must answer this question: Do you send X-rays to the OFA that your own vet feels are from a dysplastic animal? We thought not. So, if the OFA is mostly seeing "normal" hips, on what does it base its claim that the incidence of the disease is decreasing in some breeds? It also claims to have evaluated a significant percentage of those breeds most likely to be affected. 2 In the last 20 years, less than one percent of all the dogs registered by the AKC have been evaluated by OFA, so what does OFA consider significant?

Back to top

 

PREDICTING GENOTYPE

Let us now consider the diagnostic method used by the OFA and its ability to predict genotype based on phenotype. In other words, does the physical appearance of the dog tell us what genes he is carrying? This is not the case, unfortunately, because the appearance of the animal shows only the genes he is expressing. The hip-extended view used by the OFA is good for evaluating an existing problem with degenerative hip disease when that diagnosis is based upon the specific radiographic signs of osteophyte formation, subchondral sclerosis and joint remodeling, and not subluxation. In a previous article in this series, it was demonstrated that the hip-extended radiographic view actually masked joint laxity or "looseness."3 The hip-extended position actually "screws" the femoral head into closer congruity with the acetabular cup.

If there is also a correlation between joint laxity and the subsequent development of degenerative joint disease (and we feel that this already has been demonstrated), then a diagnostic method that conceals this fault may negate its predictive value. 4,5 We should also examine two other factors that can influence the effectiveness of a diagnostic method. These factors are the scoring procedure and the reproducibility of the scoring technique. The OFA uses a seven-point, subjective hip-scoring scheme that has an inherent flaw.6 When evaluating a radiograph using this method it is possible to choose between Borderline and Mild Hip Dysplasia. Because of the problems associated with wide variation in interpretation among radiologists and even the agreement of an examiner with himself or herself, this scoring technique can introduce a false-negative into the breeding pool. For our purposes as breeders, this means that a dog that should not be used for breeding is allowed to propagate, further delaying the elimination of deleterious genes.

Since the first article in this series, we have been taken to task by a number of veterinarians, anatomists and radiologists who feel that the variance in structure between breeds requires different definitions of normal hips. For example, the angle of the pelvis, flexion and elasticity of the spine and differing gaits among breeds all contribute to a separate definition of what should clinically constitute a good set of hips for a given breed. For example: the German Shepherd Dog, with its feet out somewhere in the lower 40 acres, experiences a lever and fulcrum action that exerts more force on the hip joint than if the legs were underneath the dog. It may well be-and is according to some of the veterinarians and breeders who have written in response to the earlier articles in this series-that the German Shepherd Dog must have tighter hips with deeper acetabular cups than other breeds if its hips are to be considered normal. These are issues that bring into question the practice of relying solely on radiographic evidence of hip dysplasia when there are no other clinical signs. He's 10 years old, moves like a dream, but... bad hips by radiograph. Is this a dog that has bad hips, or is there some problem with the definition of good hips?

Back to top

 

THE ROLE OF HIP LAXITY

In 1982, a group of researchers and clinicians at the University of Pennsylvania School of Veterinary Medicine, who were concerned that the incidence of canine hip dysplasia did not seem to be decreasing began to investigate the role of passive hip laxity in the development of degenerative hip disease. Using mass-selection techniques, i.e., breeding "normal" to "normal," was still producing a greater incidence of CHD than would be expected. Since a genetic screening test for this disease is not available, the problem these researchers faced was to select a phenotypic trait that was most likely to reflect the dog's genotype with respect to CHD, one that would be the least effected by environmental factors. They concluded that functional hip laxity was the most likely condition that predisposed an animal to future degenerative joint disease due to biomechanical stress on the joint and the subsequent cartilage damage. 7 Herein lies the prediction capacity of the PennHIP system. Since it is impossible to measure functional hip laxity directly they proposed that passive hip laxity was a prerequisite for functional hip laxity, though not itself a causal event. "Some dogs, in fact, have a greater tolerance for passive laxity. That a well-muscled breed may have marked passive laxity yet be naturally protected from functional hip laxity by prominent hind limb musculature." Examples of exceptionally muscled dogs are the fighting, carting and freighting dogs.

What this means is that the biomechanical stresses on the joint due to the lateral displacement of the femoral head while the dog is standing in a normal stance are different from the supine animal, yet there remains a correlation. This correlation has been tested extensively for statistical significance.

"Passive hip laxity, then, may be considered a risk factor or perhaps loosely defined, a carrier state for HD in dogs" 8

The OFA maintains that the issue of joint laxity as a predictor of CHD is neither new nor revolutionary.

"The [1972, author's note] symposium concluded and published that there was no scientific evidence to support the clinical application of palpation and/or stress radiography."9 The methodology and the scoring techniques for these early diagnostic techniques were highly subjective and depended largely on the skill and experience of the individual examiner. To address these concerns, the University of Pennsylvania researchers first determined what the normal range was for the degrees of freedom in the coxofemoral joint, where passive laxity is maximized.10 This work was necessary in order to design a precise and accurate clinical stress-radiographic method that would hold up statistically.

The canine hip has four degree of freedom. Flexion/extension is when the leg moves forward toward the belly or back away from the body-what a breeder/exhibitor would call the "side gait." Abduction/adduction is when the dog moves the leg sideways away from the body or inward toward the belly. Internal/external rotation is the twisting motion the femur can make within the acetabulum until restrained by the round ligament and the joint capsule. Lateral translation is the sideways displacement or passive laxity. Maximal passive laxity, which approximates the neutral weight-bearing stance, was obtained at 10 degrees extension, 20 degrees of abduction and 10 degrees of external rotation.11

This early study also revealed the limitations of the hip-extended radiographic view. The magnitude of lateral displacement of the femur is concealed by this view, not only because of resultant forces on the joint capsule, but there appears to be a hydrostatic effect also. The hip-extended view lowers the pressure within the joint capsule, which causes it to invaginate. A sort of vacuum or "suction" effect occurs that when combined with the fixed synovial fluid volume limits the sideways movement of the femoral head.

Back to top

 

DEVELOPING BETTER DIAGNOSTIC METHODS

Using this information, the University of Pennsylvania researchers were able to design a radiographic protocol based on quantitative parameters.12 The distraction index or DI is based on a compression radiographic view that determines where the center of the femoral head and the center of the acetabulum coincide. The distraction view then measures how far the femoral head can be moved away from the center. This view requires the use of a special device called a distractor. The proper positioning of a distractor and the amount of force is crucial. Clinicians wishing to become certified in the PennHIP method are required to attend a one-day training session. Prior to certification, in order to ensure consistency and repeatability they are also required to submit radiographs that demonstrate their proficiency to Dr. Gail Smith and his colleagues. This certification process is designed to enhance quality control and protects the all-important integrity of the PennHIP data base. Once the two views are taken, it is possible to derive a unitless variable by dividing the amount of sideways displacement from the center by the radius of the femoral head.

This variable or distraction index ranges from 0 to 1 and a later study indicated that dogs with a DI of 0.3 or lower were truly negative for CHD. Those animals with a DI of 0.7 or greater were associated with a high probability for developing dysplastic joints. A variety of statistical methods, including those that evaluate qualitative parameters, were used to evaluate their data.

The DI range between 0.3 and 0.7 is still a gray area and is most dependent on specific breed variability. In a recent publication the DI was shown to be the only statistically significant predictor of the risk of developing degenerative joint disease in Rottweilers.13 When German Shepherd Dogs were included, the results indicated they had a greater susceptibility to the disease. It is clear that further research must focus on elucidating the specific breed differences when correlating passive joint laxity and susceptibility to degenerative joint disease. As more dogs are added to the data base, it will be easier to quantify the specific DI range for each breed that indicates the disease-free phenotype. It is for this reason that every radiograph taken by a PennHIP-certified veterinarian will be submitted to PennHIP for evaluation. Breeders will not have a choice of whether to submit the radiographs or not, as is the case with veterinarians taking preliminary radiographs prior to submitting the case to OFA for interpretation and scoring. Not having this choice will make some breeders uncomfortable, but responsible breeders will be pleased to know they have contributed to the betterment of their breeds. Breeders can expect that some of their dogs that have "passed" OFA certification will not be deemed suitable for breeding using the PennHIP method.

The question needs to be answered whether it is less deleterious to breed to a dog that is genotypically positive for canine hip dysplasia than it is to lose the opportunity to breed an animal because it was a "false-positive" for canine hip dysplasia. At first such a question sounds a bit philosophical, but in practice where it hits the breeder, it has an operational answer. There will always be other dogs, other champions to be made and other suitable brood bitches and studs that can produce fine litters. It makes no sense whatsoever to risk doubling up on defective genes whether for hip dysplasia or any other known genetically transmittable disease. Once you introduce undesirable genes into your pedigree, you will have great difficulty getting them out-and it may take several human lifetimes to do so.

As we have seen previously the honor system in registries does not work. In fact it works so poorly in the AKC's registration of puppy mill animals that the Canadian government will not allow importation of AKC-registered animals if the claim is made that they are purebred. That is called fraud. It works so poorly that the U.S. Department of Agriculture found in 1992 that 70 percent of the licensed commercial dog breeders inspected did not track pedigrees accurately.14 It works so poorly that in 1987 Mark Hyland, an AKC attorney, represented to a federal judge in Kansas City that the AKC does not revoke fraudulent dog registrations because of the "infinite back up" of such registrations.15 How bad is the AKC situation?

Back to top

 

IDENTIFICATION METHODS

No one outside of AKC really knows how bad the pedigree situation is, but Alan Stern a former AKC vice president, is on record with a 1990 statement to the Sacramento Bee that fraud happens on half of AKC's registrations.16 Other registries have a similar problem with dishonesty as do Greyhound and thoroughbred racetracks. What is needed is a foolproof method for identifying a particular animal. While several identification systems are available, the Destron-Fearing microchip, now distributed by Schering-Plough, and the Avid microchip are the two contenders for the market.

Much ado has been made about the AKC wanting action on genetic problems, but until the simple matter of pedigree is cleaned up, do not look to the AKC to solve genetic problems. In author Cargill's breed, Akitas, it has only been in the past few years that AKC has allowed the breeding to Akitas imported from Japan because three separate breed registries were there. No great intellect is required to ascertain that the gene pool was artificially restricted by the AKC and that many genetic problems experienced now and that will surface in phenotype in the future will have resulted from a restricted gene pool.

Computer chip "passive responders" have been injected in dogs, cats, birds, horses fish, reptiles and exotic and endangered species since 1991. More than 2 million identification chips have been sold. These rice-size chips are injected without requiring anesthesia. They consist of a coil and a small circuit board with a one time programmable memory. The data programmed into the Avid chip's memory is encrypted, and thus not susceptible to tampering. A reader is a transceiver that transmits a radio frequency pulse (125KHz), which energizes the coil in the implanted chip, enabling it to transmit a message back to the reader.17

Although the implanted chips can be detected by X-ray, they have proven to be extremely difficult to remove, other than through advanced surgical techniques. There is one report that a staff of veterinarians were able to remove an injected chip in a horse using dual plane radiographic surgical techniques; however such imaging equipment is well beyond the reach of all but the most well-equipped veterinary centers. None of this wonderful technology has potential if costs are high, but they are not. A survey of veterinarians indicates that injection price (including the chip) is $25 to $50. Readers are available to veterinarians for less than $300. "We have the technology."

The next step in the battle against CHD is to marry up PennHIP, OFA and other evaluations with an "open" genetic registry such as the one maintained by the Institute for Genetic Disease Control in Animals (GDC).18 Unfortunately, OFA's registry is closed to outsiders, and does not require the submission of X-rays and pedigree data of all animals radiographed. PennHIP is also a closed registry, but does require submission of the cases of all animals radiographed. The authors feel so strongly about the requirement to collect and make available the phenotypical data on parents, siblings, progeny and other progeny of parents and siblings in a cross-referenced data base that they challenge both OFA and PennHIP to make their data available to some central genetic registry. The only one available and capable at present is the GDC.

Back to top

 

Conclusions:

The two major methods of diagnosing canine hip dysplasia available to the fancy in the United States are those followed by OFA and those followed by PennHIP. Both are diagnostic; however, the hip-extended protocol followed by OFA may produce false-negative results. The protocol followed by PennHIP has a prognostic or predictive capacity through the use of statistics and a carefully guarded data base that allows a prediction to be made with respect to the probability of phenotypic expression of canine hip dysplasia. No one has a clear quantification of the gray area between obviously clear and obviously dysplastic hips. Controversy still rages. Until there are open genetic registries, mandatory evaluation of all dogs registered and some assurance of pedigree validity, canine hip dysplasia will remain a common affliction of the domestic dog, especially of purebred dogs.

Back to top

 

CREDITS

References

  1. Corley, E.A. Year-end data update. Memorandum from E.A. Corley, D.V.M., Ph.D., Orthopedic Foundation for Animals, to OFA Breed Club representatives in Samoyed Club of America Bulletin,March 1995, p.15.

  2. Ibid., p.15.

  3. Cargill, J.C., Thorpe-Vargas, S. "Methods for Diagnosing the Abnormal Hip." DOG WORLD. July 1995.

  4. Lust, G.; Williams, A.J.; Burton-Wurster, N.; Pijanowski, G.T.; Bech K.; Rubin, G.; Smith, G.K. "Joint laxity and its association with hip dysplasia in Labrador Retrievers." Am J Vet Res. Vol. 54. No. 12. Pp. 1990-1999.

  5. Smith, G.K.; Gregor, T.P.; Rhodes, W.H.; Biery, D.N. "Coxofemoral joint laxity from distraction radiography and its contemporaneous and prospective correlation with laxity, subjective score, and evidence of degenerative joint disease from conventional hip-extended radiography in dogs." Am J Vet Res. 1993 Vol. 54. No. 7. Pp. 1021-1042.

  6. Corley, E.A., Keller, G.G. "Hip Dysplasia: A guide for dog breeders and owners." 2nd ed. Columbia, MO.: Orthopedic Foundation for Animals, 1989; pp. 1-27.

  7. Smith, G.K.; Biery, D.N.; Gregor, T.P. "New concepts of coxofemoral joint stability and development of a clinical stress-radiographic method for quantifying hip joint laxity in the dog." J Am Vet Med Assoc. 1990; Vol. 196, No. 1, pp. 59-70.

  8. Smith, Gregor, Rhodes and Biery. Pp. 1021-1042.

  9. Corley, E.A.; Keller, G. OFA Memorandum. Feb. 2, 1994.

  10. Heyman, S.J.; Smith, G.K.; Cofone, M.A. "Biomechanical study of the effect of coxofemoral positioning on passive hip joint laxity in dogs." Am J Vet Res. 1993;54:210-215.

  11. Smith, G.K.; Popovitch, C.A.; Gregor, T.P. "Evaluation of risk factor for degenerative joint disease associated with hip dysplasia in dogs." J Am Vet Med Assoc. 1995;206:642-647.

  12. PennHip seminar San Francisco. April 8, 1995.

  13. Smith, Popovitch and Gregor.

  14. Shook, L. "Cop tails AKC: Feds should investigate." The Spokesman-Review, Spokane, WA, December 11, 1994.

  15. Ibid.

  16. Ibid.

  17. Product data sheets. AVID, Inc., 3179 Hammer Ave. Norco, CA 91760.

  18. Institute for Genetic Disease Control in Animals (GDC), Box 222, Davis, CA 95617; (916)756-6773.

CREDITS:

Susan Thorpe-Vargas has a doctorate in immunology and has an extensive chemistry and lab background. She has been involved in numerous Environmental Protection Agency cleanup sites. Susan also raises and shows Samoyeds.

John Cargill, Retired Officer of Marines, statistician and science writer, grew up with Airedale Terriers and American Foxhounds but lives on a boat in Florida with his 5-year-old Akita.

Susan and John won the Dog Writers Association of America's Maxwell Medallion and the Iams® Eukanuba® Canine Health Award for their articles on canine genetics that appeared in DOG WORLD.

Reproduced with permission.

BEHAVIOR & HEALTH

by: Internal Article

You might not think of behavior as a health issue, but behavior problems are the number one reason why dogs end up homeless in America. Dogs who pee on the furniture, growl at the children next door, or come at grandma like an out-of-control steamroller are no fun to live with. Many of these behaviors are just naturally hardwired into dogs, though, and it's our job as their guardians to teach them how to behave in a way that is acceptable to us. It is not the dog's fault if no one ever taught him how to behave properly, or if he has insecurities that cause him to "act out." It's probably not your fault either. It's very likely that you just didn't have the information that you needed when you needed it. However, you are the one with the big primate brain and the opposable thumbs, so if your dog is going to improve, it's going to be up to you to make it happen.

Please don't be disheartened if your dog exhibits embarrassing or even dangerous behaviors. We've all been through it to one degree or another, and you can get help. This is one area where an ounce of prevention truly is worth a pound of cure. It is much easier to train a puppy than to re-train an adult dog. But don't give up if you have an older dog with some behavioral issues. There are many, many training and management techniques that will change your life and your dog's life for the better. The following links offer some of the best advice that we've seen on how to understand, modify, and manage your dog's behavior. Even more importantly, finding a competent trainer or certified behaviorist in your area can literally be a life saver for your dog.

If your dog suddenly develops uncharacteristic behavior problems, you should always check first with your veterinarian for a possible underlying illness. Chronic or acute pain, neurological disorders, diabetes, Cushing's disease, seizure disorders, hypothyroidism, and other health problems can cause unusual behavior, from house training mistakes to aggression.

Internal Article

All rights reserved.

 

Offsite References

(Links below will open in new window)

American College of Veterinary Behaviorists
To promote education and training in behavior.  Recognized by the American Board of Veterinary Specialization as the organization to promote and standardize programs for veterinarians to become board certified in veterinary behavior.
Directory of Certified Applied Animal Behaviorists - Animal Behavior Society
List of individuals professionally certified by the Animal Behavior Society as Applied or Associate Applied Animal Behaviorists.  Certification constitutes recognition by the Animal Behavior Society that, to its best knowledge, the individual meets the educational, experiential and ethical standards required by the Society for professional Applied Animal Behaviorists. 
Consultant Locator - International Association of Animal Behavior Consultants
These members have been certified as having met high professional standards and agree to abide by the organization's strict code of ethics. 
Canine Trainers and Training Tips
Association of Pet Dog Trainers
The Association of Pet Dog Trainers (APDT) is a professional organization of individual trainers who are committed to becoming better trainers t hrough education. The APDT offers individual pet dog trainers a respected and concerted voice in the dog world, and continues to promote professional trainers to the veterinary profession and to increase public awareness of dog friendly training techniques.
Flying Dog Press - Suzanne Clothier
For dog trainers & lovers from dog trainers & lovers. If you're seeking humane, relationship based training & information on dogs, behavior, training, the canine athlete, tracking, scent work, jumping, aggression and more, you're in the right place.
Karen Pryor Clicker Training
Clicker training is the popular term for the training or teaching method based on what we know about how living organisms learn.
 Clicker Solutions
Articles by Melissa Alexander and others on the art of clicker training, from basic to advanced. Use clicker training to modify problem behaviors, including aggression, house training, counter surfing, and more!
Sources of Offline Information

Dogwise.com

Online resource for dog related books and videos. Titles include works on individual breeds, activities, health and nutrition.  Large selection of training information available.

 

Please check our "Links" page for some personal web sites pertaining to this subject, and stories of affected dogs and their owners.

AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)

by: Internal Article

In dogs with AutoImmune Hemolytic Anemia (AIHA), the immune system destroys red blood cells faster than new ones can be produced. The result is anemia, or reduced red blood cells, which means less oxygen is circulated to the tissues. This disorder is occasionally seen in the Alaskan Malamute.

AIHA is most common in middle-aged dogs, and it is more often found in females than in males. Evidence of disease ranges in severity - symptoms can be mild and hardly noticeable, or severe symptoms may come on suddenly. Vague symptoms are common and include poor appetite, weakness, listlessness and lack of energy. The dog's gums may be pale, or they may be yellowish due to jaundice as a result of the breakdown of red blood cells. A dog with AIHA may have a rapid heart beat and rapid breathing. One form of AIHA (cold agglutinin disease) causes circulation problems. The ear or tail tips, or feet may become infected and dark in color.

A veterinarian will draw blood for testing to determine if a dog is anemic. Diagnosis of AIHA is made by ruling out other causes of anemia and identifying antibodies on the surface of the red blood cells. Corticosteroid treatment can slow the destruction of red blood cells. Blood transfusions are needed when the red blood cell level is critically low; transfusions can buy the dog some time while his/her own blood cell levels are recovering. Severely affected dogs may die even with the best treatment. This mostly occurs in the first few days since the onset of the episode due to kidney, liver, or heart failure, or because of a bleeding problem. Dogs that recover from an episode of AIHA may experience future relapses.

Dogs that have been diagnosed with AIHA should not be used for breeding.

Developed from the Canine Inherited Disorders Database.

Internal Article

All rights reserved.

 


Offsite Reference

(Links below will open in new window)
Autoimmune Hemolytic Anemia - Canine Inherited Disorder Database
Describes the disease and its diagnosis and treatment, as well as what to expect in living with an anemic dog.
Diagnosis of Immune-mediated Hemolytic Anemia - University of Georgia
by Drs. Hiers, Latimer, Bain & Krimer. Describes the various tests performed to diagnose this disease.

Please check our "Links" page for some personal web sites pertaining to this subject, and stories of affected dogs and their owners.

 Please check our "Links" page for some personal web sites pertaining to this subject, and stories of affected dogs and their owners.